Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Evelien F H I, Peeters"'
Autor:
Marlou W. Kluiving, Evelien F. H. I. Peeters, Titia A. Lely, Niek van Oorschot, Wendela L. de Ranitz-Greven
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Background Women are counseled preconceptionally about the potential risks of rAML progression and chance of complications during and due to pregnancy. However, a systematic search investigating the evidence on which this advice is based doe
Externí odkaz:
https://doaj.org/article/f92f24fd02a34f38a77a83db4bd98880
Autor:
Femke V. M. Mulder, Evelien F. H. I. Peeters, Jan Westerink, Fried J. T. Zwartkruis, Wendela L. de Ranitz-Greven
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-8 (2022)
Abstract Background MTOR inhibition is an effective treatment for many manifestations of tuberous sclerosis complex. Because mTOR inhibition is a disease modifying therapy, lifelong use will most likely be necessary. This study addresses the long-ter
Externí odkaz:
https://doaj.org/article/c90b1abef9fe4f0994da3c5b1a92569a
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 165
The current policy is to test en masse for access on the basis that we then have a safe system to prevent the possible spread of an epidemic virus. The question is whether this reasoning is correct. To answer this, we have developed two scenarios. On
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::966c180c1209248c6bc636388ec366c3
https://pubmed.ncbi.nlm.nih.gov/34854648
https://pubmed.ncbi.nlm.nih.gov/34854648
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 59:e117-e119
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c2c359b319f894fea54a3b00fc6900a
https://doi.org/10.1515/cclm-2020-0096
https://doi.org/10.1515/cclm-2020-0096